EUVIMEDEUVIMED entdecken
Open Access

Baclofen Inhibits Glioma Proliferation via the MEK/ERK/CREB Pathway

Boqi Zhou, Liping Shen, Xiaojie Lu

Oncology Research · 2026 · 34 (6) · 1-10

DOI: 10.32604/or.2026.079463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Boqi Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wuxi School of Medicine, Jiangnan University, Wuxi, China. Hauptthemen laut MEDLINE: Baclofen, Glioma, Cyclic AMP Response Element-Binding Protein, MAP Kinase Signaling System. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Gamma-aminobutyric acid type B (GABAB) receptors are involved in tumor progression, and baclofen exerts broad-spectrum antitumor effects in various cancers. Nevertheless, its specific function and underlying molecular mechanisms in glioma are still largely unclear. This study aimed to evaluate the effects of baclofen on glioma cells and elucidate the associated signaling pathways.

Methods

The antitumor effects of baclofen were evaluated in glioma cell lines, and its underlying molecular mechanisms were explored using transcriptome sequencing integrated with Western blotting. The in vivo antitumor efficacy of baclofen was further verified in animal models.

Results

In vitro functional assays revealed that baclofen inhibits the proliferation, migration, and invasion of glioma cells in a dose-dependent manner. Transcriptomic sequencing combined with Western blot validation demonstrated that these effects may be mediated by GABAB receptors, leading to suppressed phosphorylation of key molecules in the Mitogen-activated protein kinase kinase (MEK)/Extracellular regulated protein kinases (ERK) pathway, and consequently reduced phosphorylation of the downstream transcription factors cAMP-response element binding protein (CREB) and Fos Proto-Oncogene (FOS). Furthermore, baclofen regulates the epithelial-mesenchymal transition (EMT-like) program. All these effects were abolished by co-treatment with the specific GABAB antagonist CGP35348. In vivo experiments using a subcutaneous glioma xenograft model further verified that the continuous use of baclofen in experimental animals also demonstrated certain anti-tumor effects.

Conclusion

Collectively, these findings demonstrate that baclofen exerts anti-glioma effects through GABAB receptor-mediated inhibition of the MEK/ERK/CREB signaling axis and modulation of the EMT-like pathway, thereby highlighting the potential of baclofen as a therapeutic agent for glioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BaclofenGliomaCyclic AMP Response Element-Binding ProteinMAP Kinase Signaling SystemBrain NeoplasmsAnimalsHumansCell ProliferationMiceCell Line, TumorProto-Oncogene MasXenograft Model Antitumor AssaysCell MovementReceptors, GABA-BEpithelial-Mesenchymal TransitionGABA-B Receptor AgonistsSignal TransductionGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

GliomaMEK/ERK/CREB pathwaybaclofencancer neurosciencetranscriptome sequencing

Substanzen

BaclofenCyclic AMP Response Element-Binding ProteinProto-Oncogene MasMAS1 protein, humanReceptors, GABA-BGABA-B Receptor AgonistsCREB1 protein, human

Autor:innen und Institutionen

  • Wuxi School of Medicine, Jiangnan University, Wuxi, China.
  • Wuxi Neurosurgical Institute, Wuxi No. 2 People's Hospital (Jiangnan University Medical Center), Wuxi, China.
  • Department of Neurosurgery, Wuxi No. 2 People's Hospital (Jiangnan University Medical Center), Wuxi, China.

Zitieren

APA

Zhou, B., Shen, L., & Lu, X. (2026). Baclofen Inhibits Glioma Proliferation via the MEK/ERK/CREB Pathway. Oncology Research, 34(6), 1-10. https://doi.org/10.32604/or.2026.079463

Vancouver

Zhou B, Shen L, Lu X. Baclofen Inhibits Glioma Proliferation via the MEK/ERK/CREB Pathway. Oncology Research. 2026;34(6):1-10. doi:10.32604/or.2026.079463

BibTeX
@article{Zhou2026,
  author = {Zhou, Boqi and Shen, Liping and Lu, Xiaojie},
  title = {Baclofen Inhibits Glioma Proliferation via the MEK/ERK/CREB Pathway},
  journal = {Oncology Research},
  year = {2026},
  volume = {34},
  number = {6},
  pages = {1--10},
  doi = {10.32604/or.2026.079463}
}
Kostenlos starten →